Table 3.
Risk analysis of death with a univariate logistic mode.
| Death N = 111 |
Living N = 283 |
p (Wald test) | |
|---|---|---|---|
| Age, years (median, I and III quartile) | 58.0 (44.0–74.0) | 42.0 (8.0–64.0) | <0.0001 ∗ |
| Gender, n (%) | |||
| Male | 72 (64.9) | 187 (66.1) | 0.819 |
| Female | 39 (35.1) | 96 (33.9) | |
| Catheter, n. (%) | |||
| Yes | 99 (89.2) | 241 (85.2) | 0.128 |
| No | 12 (10.8) | 42 (14.8) | |
| Antibiotic therapy, n. (%) | |||
| Yes | 97 (87.4) | 245 (86.6) | 0.830 |
| No | 14 (12.6) | 38 (13.4) | |
| Antifungal prophylaxis, n. (%) | |||
| Yes | 36 (32.4) | 87 (30.7) | 0.745 |
| No | 75 (67.6) | 196 (69.3) | |
| Candida species, n. (%) | |||
| C. albicans | 48 (43.2) | 126 (44.5) | 0.001 |
| C. parapsilosis | 24 (21.6) | 113 (9.9) | |
| C. glabrata | 11 (9.9) | 11 (3.9) | |
| C. guilliermondii | 7 (6.3) | 12 (4.2) | |
| C. tropicalis | 8 (7.2) | 11 (3.9) | |
| C. krusei | 6 (5.4) | 5 (1.8) | |
| Other | 7 (6.3) | 5 (1.8) | |
| Department, n. (%) | |||
| Adult oncohaematology | 5 (4.5) | 18 (6.4) | <0.001 ∗∗ |
| Pediatric oncohaematology | — | 49 (17.3) | |
| NICU | 12 (10.8) | 54 (19.1) | |
| ICU | 58 (52.2) | 65 (23) | |
| General surgery | 12 (10.8) | 45 (15.9) | |
| General internal medicine | 17 (15.3) | 43 (15.2) | |
| Specialist surgery | 7 (6.3) | 8 (2.8) |
NICU: neonatal intensive care unit.
ICU: intensive care unit.
∗Wilcoxon test.
∗∗The pediatric haematology patients were excluded from analysis because none of the candidemic patients died.